KRIYA ONCOLOGY

Welcome to the Brand page for “KRIYA ONCOLOGY”, which is offered here for Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;oncology;testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “KRIYA ONCOLOGY” is believed to be currently owned by “Kriya Therapeutics, Inc.”

Owner:
KRIYA THERAPEUTICS, INC.
Owner Details
Description:
Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;ONCOLOGY;Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders;
Categories: PHARMACEUTICAL PREPARATIONS GENE THERAPY